Prestige BioPharma Limited

KOSE:A950210 Stock Report

Market Cap: ₩139.8b

Prestige BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of A950210?
Owner TypeNumber of SharesOwnership Percentage
Institutions11,4130.095%
Individual Insiders3,653,72630.4%
General Public3,824,23131.8%
Private Companies4,529,86137.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 8 shareholders own 68.18% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
21.7%
Mayson Partners Pte. Ltd.
2,602,074₩30.3b0%no data
16%
Octava Fund Limited
1,927,787₩22.4b0%no data
15.4%
So-Yeon Park
1,851,256₩21.5b0%no data
14.9%
Jinwoo Kim
1,795,720₩20.9b0%no data
0.095%
State Street Global Advisors, Inc.
11,413₩132.7m0%no data
0.05%
Ting Tan
6,000₩69.8m0%no data
0.0033%
Seok-jae Seo
400₩4.7m0%no data
0.0029%
Kyunghui Jeon
350₩4.1m0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.